How do lymphocytes kill tumor cells?

Clinical Cancer Research

Volumn 2, Issue 5, 1996, Pages 785-789

  Graubert, Timothy A ^a   Ley, Timothy J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL KILLING; CYTOTOXIC T LYMPHOCYTE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR CELL DESTRUCTION; TUMOR IMMUNITY;

ANTIGENS, CD95; CYTOTOXICITY, IMMUNOLOGIC; EXOCYTOSIS; HUMANS; LYMPHOCYTES; NEOPLASMS;

EID: 0029892665     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Fraumeni, J. F., Jr., Hoover, R. N., Devesa, S. S., and Kinlen, L. J. Epidemiology of cancer. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, Ed. 4, pp. 150-181. Philadelphia: J. B. Lippincott Co., 1993.
2. Starzl, T. E., Porter, K. A., Iwatsuki, S., Rosenthal, J. T., Shaw, B. W., Atchison, R. W., Nalesnik, M. A., Ho, M., Griffith, B. P., Hakala, T. R., Hardesty, R. L., Jaffe, R., and Bahnson, H. T. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet, 1: 583-587, 1984.
3. Mackensen, A., Carcelain, G., Viel, S., Raynal, M. C., Michalaki, H., Triebel, F., Bosq, J., and Hercend, T. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Invest., 93: 1397-1492, 1994.
4. Perren, T., and Selby, P. Biological therapy. Br. Med. J., 304: 1621-1623, 1992.
5. Zumkeller, W., and Schofield, P. N. Growth factors, cytokines, and soluble forms of receptor molecules in cancer patients. Anticancer Res., 15: 344-348, 1995.
6. Chapman, P. B., and Houghton, A. N. Non-antibody immunotherapy of cancer. Curr. Opin. Immunol., 5: 726-731, 1993.
7. Pardoll, D. M. Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol., 13: 399-415, 1995.
8. Melief, C. J. M. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res., 58: 143-175, 1992.
9. Hahn, S., Gehri, R., and Erb, P. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol. Rev., 146: 57-79, 1995.
10. Talmadge, J. E., Meyers, K. M., Prieur, D. J., and Starkey, J. R. Role of NK cells in tumour growth and metastasis in beige mice. Nature (Lond.), 284: 622-624, 1980.
11. Karre, K., Klein, G. O., Kiessling, R., Klein, G., and Roder, J. C. Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice. Nature (Lond.), 284: 624-626, 1980.
12. Russell, J. H. Internal disintegration model of cytotoxic lymphocyte-induced target damage. Immunol. Rev., 72: 97-118, 1983.
13. Vannelli, J. R., Sullivan, J. A., Mandell, G. L., and Engelhard, V. H. Reorientation and fusion of cytotoxic T lymphocyte granules after interaction with target cells as determined by high resolution cinematography. J. Immunol., 136: 377-382, 1986.
14. Lowrey, D. M., Aebischer, T., Olsen, K. J., Lichtenhelf, M., Rupp, F., Hengartner, H., and Podack, E. R. Cloning, analysis, and expression of murine perform 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9. Proc. Natl. Acad. Sci. USA, 86: 247-251, 1989.
15. Henkart, P. A. Mechanism of lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol., 3: 31-58, 1985.
16. Duke, R. C., Persechini, P. M., Chang, S., Liu, C. C., Cohen, J. J., and Young, J. D. Purified perform induces target cell lysis but not DNA fragmentation. J. Exp. Med., 170: 1451-1456, 1989.
17. Hayes, M. P., Berrebi, G. A., and Henkart, P. A. Induction of target cell DNA release by the cytotoxic T lymphocyte granule protease granzyme A. J. Exp. Med., 170: 933-946, 1989.
18. Shi, L., Kam, C-M., Powers, J. C., Aebersold, R., and Greenberg, A. H. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J. Exp. Med., 176: 1521-1529, 1992.
19. Nakajima, H., Park, H. L., and Henkart, P. A. Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin. J. Exp. Med., 181: 1037-1046, 1995.
20. Hanson, R. D., and Ley, T. J. Transcriptional activation of the human cytotoxic serine protease gene CSP-B in T lymphocytes. Mol. Cell. Biol., 10: 5655-5662, 1990.
21. Prendergast, J. A., Helgason, C. D., and Bleackley, R. C. Quantitative polymerase chain reaction analysis of cytotoxic cell proteinase gene transcripts in T cells. J. Biol. Chem., 267: 5090-5095, 1992.
22. Ebnet, K., Hausmann, M., Lehmann-Grube, F., Mullbacher, A., Kopf, M., Lamers, M., and Simon, M. M. Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J., 14: 4230-4239, 1995.
23. Velotti, F., Palmieri, G., D'Ambrosio, D., Piccoli, M., Frati, L., and Santoni, A. Differential expression of granzyme A and granzyme B proteases and their secretion by fresh rat natural killer cells (NK) and lymphokine-activated killer cells with NK phenotype (LAK-NK). Eur. J. Immunol., 22: 1049-1053, 1992.
24. Kagi, D., Ledermann, B., Burki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., and Hengartner, H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (Lond.), 369: 31-37, 1994.
25. Schulz, M., Schuurman, H-J., Joergensen, J., Steiner, C., Meerloo, T., Kagi, D., Hengartner, H., Zinkernagel, R. M., Schreier, M. H., Burki, K., and Ledermann, B. Acute rejection of vascular heart allografts by perforin-deficient mice. Eur. J. Immunol., 25: 474-480, 1995.
26. Heusel, J. W., Wesselschmidt, R. L., Shresta, S., Russell, J. H., and Ley, T. J. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell, 76: 977-987, 1994.
27. Shresta, S., MacIvor, D. M., Heusel, J. W., Russell, J. H., and Ley, T. J. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc. Natl. Acad. Sci. USA, 92: 5679-5683, 1995.
28. Graubert, T. A., Russell, J. H., and Ley, T. J. The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood, 87: 1232-1237, 1996.
29. Argyle, J. C., Kjeldsberg, C. R., Marty, J., Shigeoka, A. O., and Hill, H. R. T-cell lymphoma and the Chédiak-Higashi syndrome. Blood, 60: 672-676, 1982.
30. Roder, J. C., Haliotis, T., Klein, M., Korec, S., Jett, J. R., Ortaldo, J., Heberman, R. B., Katz, P., and Fauci, A. S. A new immunodeficiency disorder in humans involving NK cells. Nature (Lond.), 284: 553-555, 1980.
31. Baetz, K., Isaaz, S., and Griffiths, G. M. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis. J. Immunol., 154: 6122-6131, 1995.
32. Suda, T., Takahashi, T., Golstein, P., and Nagata, S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell, 75: 1169-1178, 1993.
33. Chinnaiyan, A. M., O'Rourke, K., Tewari, M., and Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81: 505-512, 1995.
34. Stanger, B. Z., Leder, P., Lee, T. H., Kim, E., and Seed, B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell, 81: 513-523, 1995.
35. Cleveland, J. L., and Ihle, J. N. Contenders in FasL/TNF death signaling. Cell, 81: 479-482, 1995.
36. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S-I., Sameshima, M., Hase, A., Seto, Y., and Nagata, S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66: 233-243, 1991.
37. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA, 91: 4185-4189, 1994.
38. Hanabuchi, S., Koyanagi, M., Kawasaki, A., Shinohara, N., Matsuzawa, A., Nishimura, Y., Kobayashi, Y., Yonehara, S., Yagita, H., and Okumura, K. Fas and its ligand in a general mechanism of T-cell mediated cytotoxicity. Proc. Natl. Acad. Sci. USA, 91: 4930-4934, 1994.
39. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata, S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell, 76: 969-976, 1994.
40. Adachi, M., Watanabe-Fukunaga, R., and Nagata, S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA, 90: 1756-1760, 1993.
41. Russell, J. H., Rush, B., Weaver, C., and Wang, R. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA, 90: 4409-4413, 1993.
42. Singer, G. G., and Abbas, A. K. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity, 1: 365-371, 1994.
43. + T cells. Immunol. Rev., 146: 223-239, 1995.
44. Rieux-Laucat, R., Le Deist, R., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., and de Villartay, J. P. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science (Washington DC), 268: 1347-1349, 1995.
45. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middelton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J., and Puck, J. M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell, 81: 935-946, 1995.
46. Sneller, M. C., Straus, S. E., Jaffe, E. S., Jaffe, J. S., Fleisher, T. A., Stetler-Stevenson, M., and Strober, W. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J. Clin. Invest., 90: 334-341, 1992.
47. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H., and Golstein, P. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science (Washington DC), 265: 528-530, 1994.
48. Lowin, B., Hahne, M., Mattmann, C., and Tschopp, I. Cytolytic T-cell cytotoxicity is mediated through perform and Fas pathways. Nature (Lond.), 370: 650-652, 1994.
49. Miura, M., Zhu, H., Rotello, R., Hartweig, E. A., and Yuan, J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell, 75: 653-660, 1993.
50. Quan, L. T., Caputo, A., Bleackley, R. C., Pickup, D. J., and Salvesen, G. S. Granzyme B is inhibited by the cowpox serpin cytokine response modifier A. J. Biol. Chem., 270: 10377-10379, 1995.
51. Dixit, V. M., and Tewari, M. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem., 270: 3255-3260, 1995.
52. Rensin-Ehl, A., Frei, K., Flury, R., Matiba, B., Mariani, S. M., Weller, M., Aebischer, P., Krammer, P. H., and Fontana, A. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol., 25: 2253-2258, 1995.